CD14 and neoplasm: Considering that CD14+ cDC2s are consistently found in peripheral blood of HDs where they also display reduced T cell stimulatory capacity vs. CD14− cDC2s, the tumor-induced expansion of CD14+ cDC2s could be tumors exploiting a homeostatic system to hamper the anti-tumor T cell responses.